Clonal hematopoiesis (CH) in long-term survivors of allogeneic hematopoietic cell transplant (HCT) remains largely understudied. Using targeted sequencing, we analyzed peripheral blood samples from 101 patients who survived without relapse for more than 10 years after HCT. The median interval from HCT to sample collect...
T. Toya, D. Sadato, C. Hirama et al.· Haematologica· 0 citations
It is suggested that targeting inflammasome signaling may represent a potential therapeutic approach for MDS through deleting Asc, an adaptor protein that links inflammasome sensor proteins to caspase-1.
Shohei Andoh, Yaeko Nakajima-Takagi, S. Uemura et al.· Experimental Hematology· 0 citations
This case suggests that sequential low-dose GO followed by stepwise DLI may support durable remission when used as a post-transplant maintenance strategy in chemo-refractory AML with adverse cytogenetics, such as t(1;3)(p36.3;q21).
Fumihiko Ouchi, Y. Najima, K. Haraguchi et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.